Agimexpharm Pharmaceutical JSC

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Agimexpharm Pharmaceutical JSC"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 6.48% vs 9.40% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 5.47% vs 12.09% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "844,674.00",
          "val2": "793,261.20",
          "chgp": "6.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "140,889.30",
          "val2": "122,108.40",
          "chgp": "15.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "39,511.70",
          "val2": "29,377.20",
          "chgp": "34.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "47,362.90",
          "val2": "44,905.20",
          "chgp": "5.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "123.20%",
          "val2": "113.70%",
          "chgp": "0.95%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

844,674.00

793,261.20

6.48%

Operating Profit (PBDIT) excl Other Income

140,889.30

122,108.40

15.38%

Interest

39,511.70

29,377.20

34.50%

Exceptional Items

0.00

0.00

Consolidate Net Profit

47,362.90

44,905.20

5.47%

Operating Profit Margin (Excl OI)

123.20%

113.70%

0.95%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 6.48% vs 9.40% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 5.47% vs 12.09% in Dec 2024

All Annual Results